BIOMAT Database Logo BIOMAT Database Logo

Pefloxacin as first-line treatment in nephrotic syndrome. 1994

C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs

UI MeSH Term Description Entries
D008297 Male Males
D009402 Nephrosis, Lipoid A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA. Glomerulonephritis, Minimal Change,Glomerulopathy, Minimal Change,Nephropathy, Minimal Change,Nephrotic Syndrome, Minimal Change,Idiopathic Minimal Change Nephrotic Syndrome,Minimal Change Disease,Minimal Change Glomerulopathy,Minimal Change Nephrotic Syndrome,Change Diseases, Minimal,Disease, Minimal Change,Diseases, Minimal Change,Glomerulonephritides, Minimal Change,Glomerulopathies, Minimal Change,Lipoid Nephroses,Lipoid Nephrosis,Minimal Change Diseases,Minimal Change Glomerulonephritides,Minimal Change Glomerulonephritis,Minimal Change Nephropathies,Minimal Change Nephropathy,Nephropathies, Minimal Change,Nephroses, Lipoid
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D005260 Female Females
D005923 Glomerulosclerosis, Focal Segmental A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE. Glomerulonephritis, Focal Sclerosing,Hyalinosis, Segmental Glomerular,Focal Segmental Glomerulosclerosis,Glomerulosclerosis, Focal,Hyalinosis, Segmental,Segmental Glomerular Hyalinosis,Focal Glomerulosclerosis,Focal Sclerosing Glomerulonephritides,Focal Sclerosing Glomerulonephritis,Glomerular Hyalinosis, Segmental,Glomerulonephritides, Focal Sclerosing,Sclerosing Glomerulonephritides, Focal,Sclerosing Glomerulonephritis, Focal,Segmental Glomerulosclerosis, Focal,Segmental Hyalinosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015366 Pefloxacin A synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria. 2589 R.B.,Abactal,Peflacine,Pefloxacin Mesylate,Pefloxacin Mesylate Dihydrate,Pefloxacine,Silver Pefloxacin,Dihydrate, Pefloxacin Mesylate,Mesylate Dihydrate, Pefloxacin,Mesylate, Pefloxacin,Pefloxacin, Silver,R.B., 2589

Related Publications

C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Pefloxacin as first-line treatment in nephrotic syndrome.
September 1992, Lancet (London, England),
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
[Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
January 1997, Nephrologie,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
More about pefloxacin and nephrotic syndrome.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Pefloxacin in the treatment of childhood nephrotic syndrome: a case report.
January 1996, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Inefficacy of pefloxacin in steroid-responsive nephrotic syndrome.
December 1995, Pediatric nephrology (Berlin, Germany),
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Side-effects of pefloxacin in idiopathic nephrotic syndrome.
August 1993, Lancet (London, England),
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy.
December 2022, Kidney international reports,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Pefloxacin in adriamycin induced nephrotic syndrome in the rat.
February 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome.
January 2000, Journal of nephrology,
C Ginsburg, and D Toledano, and G Deray, and D Vlassopoulos, and A Baumelou, and C Jacobs
[Pefloxacin as a treatment for nephrotic syndrome caused by minimal glomerular lesions in the adult: promises or deception?].
January 1997, Nephrologie,
Copied contents to your clipboard!